Cardio Diagnostics raises $1M via private placement of 561,793 units (stock + warrants) at $1.78/unit

Cardio Diagnostics Holdings, Inc.

Gross proceeds of $1,000,000 from sale of 561,793 units to 7 accredited investors at $1.78 per unit.
Each unit includes one share of common stock and a six-year warrant exercisable at $1.78 per share.
Placement agent Altitude Capital received 10% cash commission plus 112,353 warrant coverage at $1.78 through Feb 2030.
Chairman Warren Hosseinion, M.D., holds 10% ownership in Altitude Capital; recused from board approval.
Net proceeds to be used for working capital and general corporate purposes; resale registration planned within 180 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.